Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Talks

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Eye (London, England)|March 11, 2026
Real-world treatment patterns and visual outcomes of faricimab in patients with neovascular age-related macular degeneration in the UK at 12 months: the FARWIDE-nAMD studyJames Talks, Gabriella de Salvo, Praveen J Patel, et al.
Ophthalmology and Therapy|December 13, 2024
Improving Clinical Management of Diabetic Macular Edema: Insights from a Global Survey of Patients, Healthcare Providers, and Clinic StaffFocke Ziemssen, Michelle Sylvanowicz, Winfried M Amoaku, et al.
Ophthalmology and Therapy|December 13, 2024
Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular DegenerationAnat Loewenstein, Michelle Sylvanowicz, Winfried M Amoaku, et al.
Nature|September 16, 2025
Publisher Correction: TCF1 and LEF1 promote B-1a cell homeostasis and regulatory functionQian Shen, Hao Wang, Jonathan A Roco, et al.
Nature|August 20, 2025
TCF1 and LEF1 promote B-1a cell homeostasis and regulatory functionQian Shen, Hao Wang, Jonathan A Roco, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Eye (London, England)|March 11, 2026
Real-world treatment patterns and visual outcomes of faricimab in patients with neovascular age-related macular degeneration in the UK at 12 months: the FARWIDE-nAMD studyJames Talks, Gabriella de Salvo, Praveen J Patel, et al.
Ophthalmology and Therapy|December 13, 2024
Improving Clinical Management of Diabetic Macular Edema: Insights from a Global Survey of Patients, Healthcare Providers, and Clinic StaffFocke Ziemssen, Michelle Sylvanowicz, Winfried M Amoaku, et al.
Ophthalmology and Therapy|December 13, 2024
Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular DegenerationAnat Loewenstein, Michelle Sylvanowicz, Winfried M Amoaku, et al.
Nature|September 16, 2025
Publisher Correction: TCF1 and LEF1 promote B-1a cell homeostasis and regulatory functionQian Shen, Hao Wang, Jonathan A Roco, et al.
Nature|August 20, 2025
TCF1 and LEF1 promote B-1a cell homeostasis and regulatory functionQian Shen, Hao Wang, Jonathan A Roco, et al.
Pageof 7